James S. Goodwin

2.5k total citations · 3 hit papers
20 papers, 2.1k citations indexed

About

James S. Goodwin is a scholar working on Pharmacology, Immunology and Rheumatology. According to data from OpenAlex, James S. Goodwin has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Immunology and 4 papers in Rheumatology. Recurrent topics in James S. Goodwin's work include Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (4 papers) and T-cell and B-cell Immunology (4 papers). James S. Goodwin is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (4 papers) and T-cell and B-cell Immunology (4 papers). James S. Goodwin collaborates with scholars based in United States and Belgium. James S. Goodwin's co-authors include Jan Ceuppens, David R. Webb, Robert P. Searles, Ralph C. Williams, Robert W. Lightfoot, Stanisław Sierakowski, Eugeniusz J. Kucharz, R Williams, Dorothy R. Pathak and G. M. Troup and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.

In The Last Decade

James S. Goodwin

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of the immune response by prostaglandins

1980 643 citations James S. Goodwin, David R. Webb Clinical Immunology and Immunopathology profile →
Regulation of the immune response by prostaglandins

1983 617 citations James S. Goodwin, Jan Ceuppens Journal of Clinical Immunology profile →
The Effect of Marital Status on Stage, Treatment, and Survival of Cancer Patients

1987 439 citations James S. Goodwin JAMA profile →

Peers

James S. Goodwin

IMMUN

PHARM

ONCOL

MB

GENET

Keith Hillier United Kingdom

Karsten Münstedt Germany

M.G. Elder United Kingdom

Caroline B. Appleyard Puerto Rico

Peter H. Levine United States

B. Runnebaum Germany

Robert Krämer United States

David Taylor United States

M.O. Pulkkinen Finland

John S. Thompson United States

Keith Hillier United Kingdom

James S. Goodwin

299 ×0.5

IMMUN

481 ×0.9

PHARM

103 ×0.2

ONCOL

345 ×1.2

MB

307 ×1.6

GENET

Citations per year, relative to James S. Goodwin James S. Goodwin (= 1×) peers Keith Hillier

Countries citing papers authored by James S. Goodwin

Since Specialization

Citations

This map shows the geographic impact of James S. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Goodwin more than expected).

Fields of papers citing papers by James S. Goodwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Goodwin. The network helps show where James S. Goodwin may publish in the future.

Co-authorship network of co-authors of James S. Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Goodwin. A scholar is included among the top collaborators of James S. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Goodwin. James S. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Holmes, Holly M. & James S. Goodwin. (2009). Screening for prostate cancer in long-term care. 17(11). 22–28. 1 indexed citations

2.

Goodwin, James S., et al.. (2005). Postoperative Delirium in the Older Patient. Journal of the American College of Surgeons. 200(5). 767–773. 52 indexed citations

3.

Goodwin, James S.. (1991). Are prostaglandins proinflammatory, antiinflammatory, both or neither?. PubMed. 28. 26–9. 34 indexed citations

4.

Shopp, George M., et al.. (1991). Murine thymocyte lysis by inhibitors of arachidonic acid metabolism.. PubMed. 21B. 489–92. 1 indexed citations

5.

Goodwin, James S.. (1990). The Very Low Prevalence of Polymyalgia Rheumatica in Blacks May Be an Artifact. Journal of the American Geriatrics Society. 38(7). 824–826. 2 indexed citations

6.

Ledbetter, Jeffrey A., et al.. (1989). Phosphatidyl inositol hydrolysis after CD3 binding in human peripheral blood T cells: Inhibition by prostaglandin E2. International Journal of Immunopharmacology. 11(7). 809–816. 5 indexed citations

7.

Sierakowski, Stanisław, Eugeniusz J. Kucharz, Robert W. Lightfoot, & James S. Goodwin. (1989). Impaired T-cell activation in patients with systemic lupus erythematosus. Journal of Clinical Immunology. 9(6). 469–476. 35 indexed citations

8.

Goodwin, James S.. (1987). The Effect of Marital Status on Stage, Treatment, and Survival of Cancer Patients. JAMA. 258(21). 3125–3125. 439 indexed citations breakdown →

9.

Atluru, D., Elias A. Lianos, & James S. Goodwin. (1986). Arachidonic acid inhibits 5-lipoxygenase in human T cells. Biochemical and Biophysical Research Communications. 135(2). 670–676. 16 indexed citations

10.

Goodwin, James S. & Jan Ceuppens. (1983). Regulation of the immune response by prostaglandins. Journal of Clinical Immunology. 3(4). 295–315. 617 indexed citations breakdown →

11.

Searles, Robert P., et al.. (1983). Ia specific antilymphocyte antibodies in rheumatoid arthritis. Arthritis & Rheumatism. 26(4). 486–493. 18 indexed citations

12.

Ceuppens, Jan & James S. Goodwin. (1982). Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cellular Immunology. 70(1). 41–54. 44 indexed citations

13.

Searles, Robert P., et al.. (1982). Anti-Ia Reactivity in Sera from Patients with Systemic Lupus Erythematosus. Journal of Clinical Investigation. 69(1). 17–24. 50 indexed citations

14.

Goodwin, James S.. (1981). Suppressor cells in human disease. M. Dekker eBooks. 3 indexed citations

15.

Goodwin, James S.. (1981). OKT3, OKT4, and All That. JAMA. 246(9). 947–947. 6 indexed citations

16.

Goodwin, James S., et al.. (1980). Decreased sensitivity to prostaglandin and histamine in lymphocytes from normal HLA-B12 individuals: a possible role in autoimmunity.. PubMed. 125(1). 181–5. 28 indexed citations

17.

Goodwin, James S.. (1980). Modulation of conconavalin-A-induced suppressor cell activation by prostaglandin E2. Cellular Immunology. 49(2). 421–425. 33 indexed citations

18.

Goodwin, James S. & David R. Webb. (1980). Regulation of the immune response by prostaglandins. Clinical Immunology and Immunopathology. 15(1). 106–122. 643 indexed citations breakdown →

19.

Goodwin, James S.. (1980). Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of Cancer. PubMed. 2(4). 397–424. 20 indexed citations

20.

Echols, Roger, et al.. (1979). Rhizopus osteomyelitis. The American Journal of Medicine. 66(1). 141–145. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact